Comparison of the pharmacological profiles of murine antisense oligonucleotides targeting apolipoprotein B and microsomal triglyceride transfer protein.
about
Lipotoxicity in the liver.From the Cover: The Minipig is a Suitable Non-Rodent Model in the Safety Assessment of Single Stranded Oligonucleotides.Insulin resistance induces posttranslational hepatic sortilin 1 degradation in mice.Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans.Antisense technology: an emerging platform for cardiovascular disease therapeutics.Supplementary site interactions are critical for the regulation of microsomal triglyceride transfer protein by microRNA-30c.Inhibition of apolipoprotein B synthesis stimulates endoplasmic reticulum autophagy that prevents steatosisThe endoplasmic reticulum coat protein II transport machinery coordinates cellular lipid secretion and cholesterol biosynthesis.Hepatic Mttp deletion reverses gallstone susceptibility in L-Fabp knockout mice.Differential impact of hepatic deficiency and total body inhibition of MTP on cholesterol metabolism and RCT in mice.Efficacy and safety of mipomersen sodium (Kynamro).Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm development.Targeting Long Noncoding RNA with Antisense Oligonucleotide Technology as Cancer Therapeutics.Antisense oligonucleotide and thyroid hormone conjugates for obesity treatmentReduction of VLDL secretion decreases cholesterol excretion in niemann-pick C1-like 1 hepatic transgenic mice.Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice.
P2860
Q30355131-AC90A0BE-C3C0-4161-BDF9-AF7526AED13AQ33632091-8ACF5E20-D419-4AC7-A5BB-B623686319CFQ35561045-881E0741-5C40-482F-8FFC-88AD670341F6Q37093059-89207A18-F03A-4220-B85B-992A0A8A6DE9Q37337608-33760A5F-2B5E-4E4C-891F-EDED5673ACC9Q37376482-B98201FA-49F2-4019-8A6A-C6266AEC6D8FQ37395697-3AB167A5-3035-490C-A28A-2F5E6A35A1D9Q37583530-2A6BF4A5-75D2-4775-B3C3-B1CEF23AE2CAQ37603238-F7988312-6170-4D74-AC3B-3A492EFBC4E1Q37716347-206CB288-AE4D-4E5C-8D2A-22346DD444E1Q38101125-C7A92D67-E600-4539-A4B9-4304CA7283B6Q38287552-E0FDDB6F-6D9E-4E2D-97AE-B07BC41EAD36Q38807425-0A5E5B1E-941C-4561-84DD-0CA31E4BB658Q41517624-F971B15C-6C9A-46D4-AB07-7C5CB730B625Q41849738-211C6252-020C-4A4D-BD21-8E42CD9AAE95Q46457925-1F82D3CD-192C-4466-9094-3EDDDB7CC383
P2860
Comparison of the pharmacological profiles of murine antisense oligonucleotides targeting apolipoprotein B and microsomal triglyceride transfer protein.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Comparison of the pharmacologi ...... triglyceride transfer protein.
@en
Comparison of the pharmacologi ...... triglyceride transfer protein.
@nl
type
label
Comparison of the pharmacologi ...... triglyceride transfer protein.
@en
Comparison of the pharmacologi ...... triglyceride transfer protein.
@nl
prefLabel
Comparison of the pharmacologi ...... triglyceride transfer protein.
@en
Comparison of the pharmacologi ...... triglyceride transfer protein.
@nl
P2093
P2860
P356
P1476
Comparison of the pharmacologi ...... triglyceride transfer protein.
@en
P2093
Adam E Mullick
Danielle Gattis
Donna Sipe
Mark J Graham
Richard G Lee
Rosanne M Crooke
Sheri Booten
Thomas A Bell
P2860
P304
P356
10.1194/JLR.M029215
P577
2012-12-06T00:00:00Z